MECHANISMS OF ANTI-PROLIFERATIVE EFFECT PRODUCED BY MESENCHYMAL STEM CELLS IN PATIENTS WITH MULTIPLE SCLEROSIS
Abstract. We investigated the ability of autologous/allogeneic mesenchymal stem cells (MSC) from early passages, derived from bone marrow of patients with multiple sclerosis, to inhibit mitogen/myelin-induced proliferation of memory T cells. It was shown that MSC immunosuppressive potenti...
Saved in:
Main Authors: | M. M. Zafranskaya, D. B. Nizhegorodova, M. Yu. Yurkevich, S. S. Bagatka, H. I. Ivanchyk, Yana M. Motuzova, A. S. Fedulov |
---|---|
Format: | article |
Language: | RU |
Published: |
SPb RAACI
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/7f19bed10f4d40aa8b8a8c89bdb016b4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Function of the Kynurenine Pathway in the Placenta: A Novel Pharmacotherapeutic Target?
by: Michelle Broekhuizen, et al.
Published: (2021) -
Hepatocellular Carcinoma Cells Are Protected From Immunolysis by Mesenchymal Stromal Cells Through Indoleamine 2,3 Dioxygenase
by: Raghavan Chinnadurai, et al.
Published: (2021) -
Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis
by: Rivera,Francisco J, et al.
Published: (2012) -
Indoleamine-2,3-Dioxygenase as a Perioperative Marker of the Immune System
by: Corina Bello, et al.
Published: (2021) -
TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
by: V. A. Kozlov, et al.
Published: (2017)